Additional studies have paradoxically shown amelioration of Th1-mediated allograft rejection [43], EAE [25,44], and diabetes [45] in the absence of ICOS signaling, as well as enhancement of Th1-driven IgG2a production by an activatory B7h-Ig fusion protein [9]. The gene discussed is ICOSLG; the disease is diabetes mellitus.